CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab
- PMID: 30908843
- DOI: 10.1002/cyto.a.23752
CyTOF®: A New Tool to Decipher the Immunomodulatory Activity of Daratumumab
Keywords: CyTOF; anti CD38; monoclonal antibody; multiple myeloma.
Comment on
-
High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.Cytometry A. 2019 Mar;95(3):279-289. doi: 10.1002/cyto.a.23693. Epub 2018 Dec 11. Cytometry A. 2019. PMID: 30536810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials